Fluorescence lifetime imaging of E-combretastatin uptake and distribution in live mammalian cells

Bisby, RH, Botchway, SW, Hadfield, JA ORCID: https://orcid.org/0000-0001-7984-8319, McGown, A, Parker, AW and Scherer, KM 2011, 'Fluorescence lifetime imaging of E-combretastatin uptake and distribution in live mammalian cells' , European Journal of Cancer, 48 (12) , pp. 1896-1903.

PDF (Text) - Accepted Version
Download (114kB) | Preview
[img] Microsoft PowerPoint (Figures) - Accepted Version
Download (9MB)
[img] Microsoft Word (Text) - Accepted Version
Restricted to Repository staff only

Download (54kB)


To investigate within live mammalian cells the uptake and disposition of combretastatins, fluorescence lifetime imaging was used with two-photon excitation (2PE). Combretastatin A4 (CA4) and analogues are potential anticancer drugs due to their ability to inhibit angiogenesis. E(trans)-combretastatins are considerably less active than the Z(cis)-combretastatins proposed for clinical use. However the E combretastatins exhibit stronger intrinsic fluorescence with quantum yields and lifetimes that depend markedly on solvent polarity and viscosity. It is proposed that 2PE in the red and near-infrared tissue window may allow in situ isomerization of E-combretastatins to the more active Z-isomer, offering spatial and temporal control of drug activation and constitute a novel form of photodynamic therapy. In the present work we have characterised 2PE of E-CA4 and have used fluorescence lifetime imaging with 2PE to study uptake and intracellular disposition of E-CA4 and an analogue. The results show that these molecules accumulate rapidly in cells and are located mainly in lipidic environments such as lipid droplets. Within the droplets the local concentrations may be up to 2 orders of magnitude higher than that of the drug in the surrounding medium.

Item Type: Article
Themes: Health and Wellbeing
Schools: Schools > School of Environment and Life Sciences > Biomedical Research Centre
Journal or Publication Title: European Journal of Cancer
Publisher: Elsevier
Refereed: Yes
ISSN: 0959-8049
Related URLs:
Funders: Science and Technology Facilities Council (STFC)
Depositing User: RH Bisby
Date Deposited: 12 Jan 2012 10:29
Last Modified: 16 Feb 2022 14:03
URI: https://usir.salford.ac.uk/id/eprint/19344

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)


Downloads per month over past year